4.7 Review

Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials

Related references

Note: Only part of the references are listed.
Article Dermatology

Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a Phase 3 double-blind randomized, controlled trial

C. Bodemer et al.

Summary: In a study involving pediatric patients with severe chronic plaque psoriasis, both doses of Secukinumab (LD and HD) demonstrated high and sustained efficacy over one year, with a favorable safety profile.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Article Dermatology

Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations

Paolo Gisondi et al.

Summary: The study provides expert consensus recommendations for treat-to-target strategy in psoriasis, focusing on clinical remission, quality of life, abrogation of systemic inflammation, and safety. Treatment goals should be achieved within 3-4 months, with a 90% improvement in PASI score or a PASI score of less than or equal to 3, as well as improvements in quality of life and satisfaction.

DERMATOLOGY AND THERAPY (2021)

Article Dermatology

Relationship between PASI and FDLQI in paediatric psoriasis, and treatments used in daily clinical practice

Emma Kim et al.

Summary: This study investigated the impact of pediatric psoriasis on family quality of life, finding a strong correlation between disease severity and adverse quality of life for family members. Most patients showed improvement through topical therapy.

AUSTRALASIAN JOURNAL OF DERMATOLOGY (2021)

Article Medicine, General & Internal

Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy

Ylenia Ingrasciotta et al.

Summary: A potential undertreatment of PsO (much less for PsA) in an LHU from Southern Italy, with a particularly low use of more recently marketed drugs, such as biological ones, was shown.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Dermatology

Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis

Kyle Fahrbach et al.

Summary: This study compared the short-term clinical efficacy of approved biologic treatments for moderate-to-severe Psoriasis Area and Severity Index (PASI) levels, finding that interleukin inhibitors were the best performing treatments for achieving all PASI levels.

DERMATOLOGY AND THERAPY (2021)

Article Dermatology

Challenges in the treatment of psoriasis in childhood

Klara Cvenkel et al.

Summary: Psoriasis is a chronic, immune-mediated, inflammatory skin disease that affects up to 1.2% of children and adolescents. Treatment options for pediatric psoriasis are mostly off-label and lack data on efficacy and safety, posing a challenge for effective management of the condition. Conducting new pediatric clinical trials is necessary to broaden the therapeutic spectrum for psoriasis in children and adolescents.

ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA (2021)

Letter Dermatology

Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy

M. Talamonti et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Review Medicine, General & Internal

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis

Emilie Sbidian et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)

Review Dermatology

Severity scores for childhood psoriasis: A systematic literature review

J. Lavaud et al.

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2019)

Article Dermatology

Evaluation of cutaneous surface parameters in psoriatic patients

S. P. Cannavo et al.

SKIN RESEARCH AND TECHNOLOGY (2017)

Article Pediatrics

Treatment of severe psoriasis in children: recommendations of an Italian expert group

Anna Belloni Fortina et al.

EUROPEAN JOURNAL OF PEDIATRICS (2017)

Article Biotechnology & Applied Microbiology

Adalimumab for treating childhood plaque psoriasis: a clinical trial evaluation

Vito Di Lernia

EXPERT OPINION ON BIOLOGICAL THERAPY (2017)

Article Dermatology

Treatment patterns with systemic antipsoriatic agents in childhood psoriasis: an Italian database analysis

Vito Di Lernia et al.

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA (2017)

Letter Dermatology

Systemic treatments in childhood psoriasis: a French multicentre study on 154 children

L. Charbit et al.

BRITISH JOURNAL OF DERMATOLOGY (2016)

Review Dermatology

Systemic Treatment of Pediatric Psoriasis: A Review

Maddalena Napolitano et al.

DERMATOLOGY AND THERAPY (2016)

Article Medicine, General & Internal

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

David Moher et al.

SYSTEMATIC REVIEWS (2015)

Review Dermatology

Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

Rosa Parisi et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)

Article Dermatology

Epidemiology and comorbidity of psoriasis in children

M. Augustin et al.

BRITISH JOURNAL OF DERMATOLOGY (2010)

Article Dermatology

Incidence of psoriasis in children: A population-based study

Megha M. Tollefson et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)

Article Medicine, General & Internal

Etanercept treatment for children and adolescents with plaque psoriasis

Amy S. Paller et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Dermatology

Current severe psoriasis and the Rule of Tens

AY Finlay

BRITISH JOURNAL OF DERMATOLOGY (2005)

Article Dermatology

A comparative study of pediatric onset psoriasis with adult onset psoriasis

SP Raychaudhuri et al.

PEDIATRIC DERMATOLOGY (2000)